Rahul Lakhotia

Rahul Lakhotia, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Lymphoid Malignancies Branch


Rahul Lakhotia's clinical research focuses on the development of novel targeted therapy and immunotherapy for treatment of indolent and aggressive non-Hodgkin lymphomas. Another area of interest is the development of novel lymphoma-specific biomarkers such as circulating tumor DNA for prognostication and monitoring of treatment response and relapse.

Areas of Expertise

Follicular Lymphoma
Mantle Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Targeted Therapy

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them.


Selected Recent Publications

Circulating tumor DNA predicts therapeutic outcome in mantle cell lymphoma

Lakhotia R, Melani C, Dunleavy K, Pittaluga S, Saba N, Lindenberg L, Mena E, Bergvall E, Lucas AN, Jacob A, Yusko E, Steinberg SM, Jaffe ES, Wiestner A, Wilson WH, Roschewski M.
Blood Advances. 6/8: 2667-2680, 2022. [ Journal Article ]

Circulating tumour DNA in B-cell lymphomas: current state and future prospects

Lakhotia R, Roschewski M.
Br J Haematol. 193/5: 867-881, 2021. [ Journal Article ]

Is Dose-Adjusted EPOCH-R Less Effective in Children Than Adults With Primary Mediastinal B-Cell Lymphoma?

Lakhotia R, Melani C, Roschewski M, Wilson WH.
J Clin Oncol.. 40/18: 2063-2064, 2022. [ Journal Article ]

Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL

Miljkovic MD, Melani C, Pittaluga S, Lakhotia R, Lucas N, Jacob A, Yusko E, Jaffe ES, Wilson WH, Roschewski M.
Blood Advances. 5/20: 4198-4210, 2021. [ Journal Article ]

Measurement of circulating tumor DNA to guide management of patients with lymphoma

Sriram D, Lakhotia R, Fenske TS.
Clin Adv Hematol Oncol.. 17/9: 509-517, 2019. [ Journal Article ]